ArticleSouth Asian journal of cancer2024

Lenvatinib Can Overcome Immune Resistance in Head and Neck Cancer and Achieve Durable Remission.

Oshin Suri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.